If you don’t have Acrobat® Reader®, click here for a free and secure download.
MIRAPEX is a medication used in the treatment of moderate-to-severe primary restless legs syndrome (RLS). Restless legs syndrome is a neurological sensorimotor disorder characterized by an urge to move legs in an effort to alleviate the effects of leg symptoms.1 Clinical trials of patients taking MIRAPEX for RLS have demonstrated significant improvement in range of RLS symptoms compared with placebo.2,3
Important Information about MIRAPEX: MIRAPEX is indicated for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS).
Patients have reported falling asleep without perceived warning signs during activities of daily living, including operation of a motor vehicle, which sometimes resulted in accidents. Hallucinations and postural (orthostatic) hypotension may occur. In clinical trials for RLS, the most commonly reported side effects of MIRAPEX that were more frequent than with placebo are nausea (16% vs. 5%), headache (16% vs. 15%), fatigue (9% vs. 7%) and somnolence (6% vs. 3%).
Patients and caregivers should be informed that impulse control disorders and compulsive behaviors have been reported in patients taking dopamine agonists, including MIRAPEX.
This information is intended for U.S. residents only. Products discussed herein may have different labeling in different countries.
Please see full Prescribing Information, including patient information.
